OAS2 antibody
Principal name
OAS2 antibody
Alternative names for OAS2 antibody
2-5A synthetase 2, p69 OAS, p71 OAS, 2'-5'-oligoadenylate synthetase 2, (2-5')oligo(A) synthetase 2
SwissProt ID
P29728 (Human)
Gene ID
4939 (OAS2)
Ncbi ID
9606, NP_002526, NP_058197, NP_002526.2, NM_002535, NM_016817, NM_001032731
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB), Paraffin Sections (P), Enzyme Immunoassay (E)
Background of OAS2 antibody
- Kit Component:
- - KN208273G1, OAS2 gRNA vector 1 in pCas-Guide vector
- KN208273G2, OAS2 gRNA vector 2 in pCas-Guide vector
- KN208273D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual

Human SH-SYSY; WB Suggested Anti-OAS2 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:1562500. Positive Control: SH-SYSY cell lysate; OAS2 antibody - N-terminal region (ARP40851_P050) in Human SH-SYSY cells using Western Blot

Human Lung; WB Suggested Anti-OAS2 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: Human Lung; OAS2 antibody - middle region (ARP40852_P050) in Human Lung cells using Western Blot

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY OAS2 (RC208273, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-OAS2.

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY OAS2 (RC208273, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-OAS2.

Immunohistochemical staining of paraffin-embedded Human lymphoma tissue using anti-OAS2 mouse monoclonal antibody. (TA802772) Dilution: 1:150

Immunohistochemical staining of paraffin-embedded Human lymph node tissue within the normal limits using anti-OAS2 mouse monoclonal antibody. (TA802772) Dilution: 1:150

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY OAS2 (RC208273, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-OAS2.

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY OAS2 (RC208273, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-OAS2.

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY OAS2 (RC208273, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-OAS2.

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY OAS2 (RC208273, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-OAS2.

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY OAS2 (RC208273, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-OAS2.

Immunohistochemical staining of paraffin-embedded Human lymphoma tissue using anti-OAS2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min, TA802824)

Immunohistochemical staining of paraffin-embedded Human lymph node tissue within the normal limits using anti-OAS2 mouse monoclonal antibody. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min, TA802824)

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY OAS2 (RC208273, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-OAS2.

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY OAS2 (RC208273, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-OAS2.

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY OAS2 (RC208273, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-OAS2.

Anti-OAS2 antibody (1µg/ml) staining of Jurkat lysate (35µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.

Anti-OAS2 antibody (0.3µg/ml) staining of Daudi (A), Jurkat (B) and K562 (C) lysates (35µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA327760 | OAS2 antibody |
||||||
| OAS2 Goat Polyclonal Antibody | |||||||
![]() |
Goat | Aff - Purified | Hu | E, WB |
0.1 mg /
€360.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA327761 | OAS2 (357-371) antibody |
||||||
| OAS2 Goat Polyclonal Antibody | |||||||
![]() |
Goat | Aff - Purified | Hu | E, WB |
0.1 mg /
€360.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA349422 | OAS2 antibody |
||||||
| Rabbit Polyclonal Anti-OAS2 Antibody | |||||||
![]() |
Rabbit | IgG | Purified | Hu, Ms | E, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA802770 | OAS2 antibody |
||||||
| OAS2 mouse monoclonal antibody, clone OTI3C1 (formerly 3C1) | |||||||
![]() |
Mouse | IgG2a | OTI3C1 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| TA802771 | OAS2 antibody |
||||||
| OAS2 mouse monoclonal antibody, clone OTI4B11 (formerly 4B11) | |||||||
![]() |
Mouse | IgG1 | OTI4B11 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| TA802772 | OAS2 antibody |
||||||
| OAS2 mouse monoclonal antibody, clone OTI6E6 (formerly 6E6) | |||||||
![]() |
Mouse | IgG2a | OTI6E6 | Purified | Hu | P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
+2 additional images |
|||||||
| TA802773 | OAS2 antibody |
||||||
| OAS2 mouse monoclonal antibody, clone OTI2A1 (formerly 2A1) | |||||||
![]() |
Mouse | IgG2a | OTI2A1 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| TA802786 | OAS2 antibody |
||||||
| OAS2 mouse monoclonal antibody, clone OTI3A3 (formerly 3A3) | |||||||
![]() |
Mouse | IgG1 | OTI3A3 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| TA802805 | OAS2 antibody |
||||||
| OAS2 mouse monoclonal antibody, clone OTI5C3 (formerly 5C3) | |||||||
![]() |
Mouse | IgG1 | OTI5C3 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| TA802806 | OAS2 antibody |
||||||
| OAS2 mouse monoclonal antibody, clone OTI5C10 (formerly 5C10) | |||||||
![]() |
Mouse | IgG1 | OTI5C10 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| TA802824 | OAS2 antibody |
||||||
| OAS2 mouse monoclonal antibody, clone OTI5E1 (formerly 5E1) | |||||||
![]() |
Mouse | IgG2a | OTI5E1 | Purified | Hu | P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
+2 additional images |
|||||||
| TA802825 | OAS2 antibody |
||||||
| OAS2 mouse monoclonal antibody, clone OTI2G3 (formerly 2G3) | |||||||
![]() |
Mouse | IgG1 | OTI2G3 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
| TA802886 | OAS2 antibody |
||||||
| OAS2 mouse monoclonal antibody, clone OTI3D4 (formerly 3D4) | |||||||
![]() |
Mouse | IgG2b | OTI3D4 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY400905 | OAS2 overexpression lysate |
|
![]() |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |








+2 additional images






